X3xkjqct8ugf8qboquwx cergentis

Cergentis

Utrecht, NL

Cergentis provides services and kits for targeted complete Next Generation Sequencing (NGS), based on its proprietary Targeted Locus Amplification (TLA) Technology.

Uniquely, TLA (Nature Biotech, 2014) enables targeted complete NGS and haplotyping of any gene of interest and detection of all Single Nucleotide Variants and Structural Changes.

Cergentis provides the following services:

  1. transgene and integration site sequencing in transgenic cell lines and -animal models
  2. complete sequencing and QC of (targeted) gene editing events
  3. complete targeted sequencing of oncogenes
  4. complete targeted sequencing & haplotyping

Cergentis works for leading research institutes, diagnostic labs and pharmaceutical and biotech companies globally.

For more information: www.cergentis.com

To view our Nature Biotech publication: www.nature.com/articles/nbt.2959

Cergentis has not listed any services.

Ask A Question Find what you're looking for? If not, you can ask this lab a question:
TLA-Based Next Generation Sequencing
Targeted Locus Amplification Sequencing
Price on request

TLA enables the targeted complete sequencing of:

-transgene integration site(s)
-structural variation surrounding the integration site(s)
-structural variation in the transgene sequence
-SNVs in the transgene sequence

TLA based services consist of TLA prep, TLA amplification, NGS sequencing and data analysis.

The... Show more »

TLA enables the targeted complete sequencing of:

-transgene integration site(s)
-structural variation surrounding the integration site(s)
-structural variation in the transgene sequence
-SNVs in the transgene sequence

TLA based services consist of TLA prep, TLA amplification, NGS sequencing and data analysis.

The standard turnaround time is 6 weeks.

Cergentis supports leading research institutes, biotech & pharmaceutical companies in the development and quality control of transgenic (CHO) cell-lines, CAR-T cells and (animal) models.

TLA-Based Targeted Sequencing & Haplotyping of Genes of Interest

TLA enables the targeted complete Next Generation Sequencing & haplotyping of any gene in any genome.

TLA based services consist of TLA prep, TLA amplification, NGS sequencing and data analysis.

The standard turnaround time is 6 weeks.

Cergentis supports leading research institutes and pharmaceutical companies in the targeted sequencing and haplotyping of genes of interest.

TLA-Based Sequencing of Oncogenes

TLA enables the complete targeted complete Next Generation Sequencing of oncogenes, and the detection of all SNVs and structural changes. In addition, TLA-based sequencing of gene fusion breakpoint sequences is used for the development of Minimal Residual Disease tests in (pediatric) leukemia.

TLA based services consist of TLA prep, TLA amplification, NGS sequencing and data analysis.

The standard turnaround time is 6 weeks.

Cergentis supports oncogenetic research and the development of MRD tests.

« Show less
Human
Hamster
Rabbit
Plant
Mouse
Pig
Rat
Next Generation Sequencing
CHO
Illumina
NGS
gDNA
cells
2018-05-18 15:14:56 -0400

Net Promoter Score of 10 received for TLA-Based Next Generation Sequencing.

2017-09-01 13:21:18 -0400

Net Promoter Score of 10 received for TLA-Based Next Generation Sequencing.

Additional Ratings: satisfaction with deliverable: 9, satisfaction with timeliness: 9.

Be the first to endorse Cergentis

Endorse this lab